|
1
|
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.
|
Ann Oncol
|
2012
|
1.78
|
|
2
|
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.
|
Pharmacogenomics J
|
2010
|
1.33
|
|
3
|
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.
|
J Clin Oncol
|
2001
|
1.32
|
|
4
|
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
|
Ann Oncol
|
2012
|
1.28
|
|
5
|
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.
|
Ann Oncol
|
2007
|
1.28
|
|
6
|
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
|
Ann Oncol
|
2007
|
1.08
|
|
7
|
Adjuvant colon cancer chemotherapy: where we are and where we'll go.
|
Cancer Treat Rev
|
2010
|
1.05
|
|
8
|
Primary Hodgkin's disease of the stomach. A case report.
|
Tumori
|
1992
|
0.97
|
|
9
|
Molecularly targeted endocrine therapies for breast cancer.
|
Cancer Treat Rev
|
2010
|
0.96
|
|
10
|
New molecular targets in bone metastases.
|
Cancer Treat Rev
|
2010
|
0.95
|
|
11
|
Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
|
Ann Oncol
|
2006
|
0.94
|
|
12
|
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.
|
Breast Cancer Res Treat
|
1996
|
0.89
|
|
13
|
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study.
|
Ann Oncol
|
2007
|
0.89
|
|
14
|
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).
|
Ann Oncol
|
2011
|
0.89
|
|
15
|
Agreement between oncology guidelines and clinical practice in Italy: the 'right' program. A project of the Italian Association of Medical Oncology (AIOM).
|
Ann Oncol
|
2007
|
0.85
|
|
16
|
Update on capecitabine alone and in combination regimens in colorectal cancer patients.
|
Cancer Treat Rev
|
2010
|
0.85
|
|
17
|
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
|
Melanoma Res
|
2003
|
0.84
|
|
18
|
Computed-tomographic-guided biopsy of thoracic nodules: a revision of 583 lesions.
|
Clin Ter
|
2008
|
0.82
|
|
19
|
Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter?
|
Med Oncol
|
2011
|
0.81
|
|
20
|
Cis-diamminedichloroplatinum activity in bidimensionally measurable metastatic lesions of bladder carcinoma.
|
Tumori
|
1984
|
0.79
|
|
21
|
MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
|
Oncology
|
2010
|
0.78
|
|
22
|
Cetuximab in squamous cell head and neck carcinomas.
|
Ann Oncol
|
2007
|
0.78
|
|
23
|
Role of prognostic factors in the therapeutic strategy of primary gastric non Hodgkin's lymphomas.
|
Clin Ter
|
1998
|
0.78
|
|
24
|
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.
|
Med Oncol Tumor Pharmacother
|
1989
|
0.78
|
|
25
|
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
|
Cancer
|
1999
|
0.77
|
|
26
|
5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
|
Anticancer Res
|
1999
|
0.77
|
|
27
|
Postchemotherapy residual masses in germ cell tumor patients: our experience.
|
Ann Oncol
|
2006
|
0.77
|
|
28
|
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
|
Am J Clin Oncol
|
1999
|
0.76
|
|
29
|
Efficacy of the association of folinic acid and 5-fluorouracil alone versus folinic acid and 5-fluorouracil plus 4-epidoxorubicin in the treatment of advanced gastric carcinoma.
|
Am J Clin Oncol
|
1995
|
0.76
|
|
30
|
Carboplatin and etoposide in previously treated colorectal cancer patients.
|
Tumori
|
1995
|
0.76
|
|
31
|
Malignant melanoma metastatic to the right atrium: clinical findings of an asyntomatic case.
|
Minerva Cardioangiol
|
2008
|
0.75
|
|
32
|
Role of external radiation therapy in urinary cancers.
|
Ann Oncol
|
2007
|
0.75
|
|
33
|
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
|
Ann Oncol
|
2017
|
0.75
|
|
34
|
Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
|
Tumori
|
1988
|
0.75
|
|
35
|
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
|
Ann Oncol
|
2017
|
0.75
|
|
36
|
Sequential treatment with high-dose methotrexate and fluorouracil in advanced colorectal cancer. Experience of the Southern Italian Oncology Group (GOIM).
|
J Chemother
|
1994
|
0.75
|
|
37
|
[Are endocrine receptors determining factors for the prognosis of carcinoma of the breast?].
|
Ric Clin Lab
|
1985
|
0.75
|
|
38
|
Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM).
|
Anticancer Res
|
1995
|
0.75
|
|
39
|
Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer.
|
Breast Cancer Res Treat
|
1988
|
0.75
|
|
40
|
Single agent vinorelbine in the treatment of unresectable lung metastases from colorectal cancer.
|
Oncol Rep
|
1996
|
0.75
|
|
41
|
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM).
|
Oncology
|
1996
|
0.75
|